Cargando…

Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis

Detalles Bibliográficos
Autores principales: Martínez-Pérez, Rosalía, Rodríguez-Montero, Sergio, Muñoz, Alejandro, Uceda, Julia, León, Mario, Gallo, Francisco, Velloso, Maria Luisa, Marenco, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509080/
http://dx.doi.org/10.1186/1479-5876-10-S3-P51
_version_ 1782251286417113088
author Martínez-Pérez, Rosalía
Rodríguez-Montero, Sergio
Muñoz, Alejandro
Uceda, Julia
León, Mario
Gallo, Francisco
Velloso, Maria Luisa
Marenco, José Luis
author_facet Martínez-Pérez, Rosalía
Rodríguez-Montero, Sergio
Muñoz, Alejandro
Uceda, Julia
León, Mario
Gallo, Francisco
Velloso, Maria Luisa
Marenco, José Luis
author_sort Martínez-Pérez, Rosalía
collection PubMed
description
format Online
Article
Text
id pubmed-3509080
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35090802012-12-03 Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis Martínez-Pérez, Rosalía Rodríguez-Montero, Sergio Muñoz, Alejandro Uceda, Julia León, Mario Gallo, Francisco Velloso, Maria Luisa Marenco, José Luis J Transl Med Poster Presentation BioMed Central 2012-11-28 /pmc/articles/PMC3509080/ http://dx.doi.org/10.1186/1479-5876-10-S3-P51 Text en Copyright ©2012 Martínez-Pérez et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Martínez-Pérez, Rosalía
Rodríguez-Montero, Sergio
Muñoz, Alejandro
Uceda, Julia
León, Mario
Gallo, Francisco
Velloso, Maria Luisa
Marenco, José Luis
Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
title Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
title_full Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
title_fullStr Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
title_full_unstemmed Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
title_short Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
title_sort clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509080/
http://dx.doi.org/10.1186/1479-5876-10-S3-P51
work_keys_str_mv AT martinezperezrosalia clinicalandeconomicefficiencytoreducedoseetanerceptandadalimumabinpatientswithrheumatoidarthritis
AT rodriguezmonterosergio clinicalandeconomicefficiencytoreducedoseetanerceptandadalimumabinpatientswithrheumatoidarthritis
AT munozalejandro clinicalandeconomicefficiencytoreducedoseetanerceptandadalimumabinpatientswithrheumatoidarthritis
AT ucedajulia clinicalandeconomicefficiencytoreducedoseetanerceptandadalimumabinpatientswithrheumatoidarthritis
AT leonmario clinicalandeconomicefficiencytoreducedoseetanerceptandadalimumabinpatientswithrheumatoidarthritis
AT gallofrancisco clinicalandeconomicefficiencytoreducedoseetanerceptandadalimumabinpatientswithrheumatoidarthritis
AT vellosomarialuisa clinicalandeconomicefficiencytoreducedoseetanerceptandadalimumabinpatientswithrheumatoidarthritis
AT marencojoseluis clinicalandeconomicefficiencytoreducedoseetanerceptandadalimumabinpatientswithrheumatoidarthritis